Financial Personal
Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company
Cosmetic registration and delivery into Germany completed in preparation for the initial commercial Launch TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial
Cosmetic registration and delivery into Germany completed in preparation for the initial commercial Launch Read More
